Background: Transfers and IRS Scrutiny
Perrigo’s case involved income earned by its Israeli
affiliate from sales of omeprazole between 2009 and 2012. The IRS challenged
Perrigo’s transfer pricing arrangements, alleging the use of a foreign
subsidiary amounted to an artificial structure designed primarily for tax
avoidance. Instead of relying solely on Section 482, the well-established
transfer pricing framework, the IRS pressed its case by invoking the codified
economic substance doctrine, arguing that the subsidiary and related-party
transactions lacked legitimate business purpose.
The Court’s Decision: Section 482 Prevails
The Michigan federal court rejected the government’s position, affirming that Perrigo’s arrangements fell squarely within the regulatory boundaries set by Section 482.
The Court Declined To Give PrecedenceTo The IRS’s Economic Substance Arguments, Noting That The Detailed Transfer Pricing Rules Already
Encompass The Necessary Tests For Legitimacy, Including Whether Transactions Have Real Economic Substance.
Ultimately, the court found in favor of Perrigo, recognizing the validity of its cross-border arrangements and rendering the company entitled to much of its $163 million tax refund. The decision limits the reach of the economic substance doctrine in cases where Congress has crafted a detailed regulatory framework.
Lessons for Multinationals and Practitioners
This case highlights a crucial crossroads in international
tax law. While the IRS has signaled a more aggressive strategy using the
economic substance doctrine to challenge cross-border transactions, this court
ruling underscores the primacy of specific transfer pricing regulations when
they fully address the relevant issues. The outcome is a welcome development
for businesses relying on robust documentation and arm’s-length principles in
their international structures.
The ruling also sends a clear message: courts may resist
broad anti-avoidance doctrines when a statutory or regulatory scheme like
Section 482 already provides detailed rules and oversight. Nevertheless,
taxpayers should anticipate continued IRS scrutiny of related-party
transactions and be prepared to defend both the economic substance and the
arm’s-length nature of their structures.
Conclusion
The Perrigo case is a bellwether for future disputes at the
nexus of transfer pricing and economic substance. Multinationals can take some
comfort that careful compliance with Section 482 remains a strong defense, but
vigilance is still required as the IRS refines its strategies and aggressively
asserts penalties in international tax cases. The evolving landscape calls for
sophisticated planning and, above all, meticulous substantiation of global tax
positions.
Contact the Tax Lawyers at
www.TaxAid.com or www.OVDPLaw.com
or Toll Free at 888 8TAXAID (888-882-9243)
Sources:
1. https://www.law360.com/articles/2392644/perrigo-mostly-beats-us-in-163m-tax-refund-dispute
2.
https://papers.ssrn.com/sol3/Delivery.cfm/SSRN_ID3901985_code384494.pdf?abstractid=3901985&mirid=1&type=2
3.
https://www.law360.com/tax-authority/international/articles/2392644/perrigo-mostly-beats-us-in-163m-tax-refund-dispute
4.
https://www.grayreed.com/portalresource/TopFederalCases2024
5.
https://www.forbes.com/sites/taxnotes/2024/04/01/will-the-economic-substance-doctrine-and-its-potential-tax-consequences-swallow-transfer-pricing/
6.
https://insightplus.bakermckenzie.com/bm/dispute-resolution/united-states-irs-signals-increased-assertion-of-the-economic-substance-doctrine-and-related-penalties-in-transfer-pricing-cases
7.
https://www.caplindrysdale.com/news-clark-armitage-weighs-in-on-transfer-pricing-in-2025-in-tax-notes
8.
https://www.pacermonitor.com/public/filings/DXIJBTHA/Perrigo_Company_v_United_States_of_America__miwdce-17-00737__0395.0.pdf
9.
https://www.cadwalader.com/resources/patent-litigation-tracker/trial-page-2
10.
https://www.reuters.com/legal/government/us-judge-rules-against-perrigo-over-19-billion-irish-tax-liability-2021-07-16/
11.
https://www.strategicclaims.net/wp-content/uploads/2025/08/2025.07.30_Doc.-82_Decl.-ISO-Final-Approval-1.pdf
12.
https://www.law360.com/tax-authority/articles/2392644/perrigo-mostly-beats-us-in-163m-tax-refund-dispute
13.
https://grabsecuritiessettlement.com/media/xzlfdutl/151-20250410-grab-joint-declaration.pdf
14.
http://www.sec.gov/Archives/edgar/data/1585364/000158536424000113/R23.htm
15.
https://www.nytimes.com/2022/07/07/business/perrigo-omeprazole-taxes-ey.html
16.
https://www.ftc.gov/legal-library/browse/cases-proceedings/012-3121-perrigo-company-matter
17.
https://investor.perrigo.com/2021-09-29-Perrigo-Resolves-Irish-Tax-Assessment-for-EUR297-million
18.
https://tpcases.com/pop-pages/us/
19.
https://www.law360.com/tax-authority/dockets/68d57dc30a17f744c2a696c2
20. https://www.law360.com/tax-authority/articles/1208763
21.
https://www.law360.com/articles/2392644/perrigo-mostly-beats-us-in-163m-tax-refund-dispute
22.
https://www.caplindrysdale.com/news-clark-armitage-weighs-in-on-transfer-pricing-in-2025-in-tax-notes
23.
https://www.forbes.com/sites/taxnotes/2024/04/01/will-the-economic-substance-doctrine-and-its-potential-tax-consequences-swallow-transfer-pricing/
24. https://insightplus.bakermckenzie.com/bm/dispute-resolution/united-states-irs-signals-increased-assertion-of-the-economic-substance-doctrine-and-related-penalties-in-transfer-pricing-cases
25.
https://law.justia.com/cases/federal/appellate-courts/ca3/24-2861/24-2861-2025-08-12.html
26. https://www.vitallaw.com/news/us-irs-drops-transfer-pricing-case-against-pharma-giant-perrigo/gdn01163640
27.
https://www.law360.com/articles/2392644/perrigo-mostly-beats-us-in-163m-tax-refund-dispute
28. https://insightplus.bakermckenzie.com/bm/dispute-resolution/united-states-irs-signals-increased-assertion-of-the-economic-substance-doctrine-and-related-penalties-in-transfer-pricing-cases
29. https://www.forbes.com/sites/taxnotes/2024/04/01/will-the-economic-substance-doctrine-and-its-potential-tax-consequences-swallow-transfer-pricing/
30. https://www.caplindrysdale.com/news-clark-armitage-weighs-in-on-transfer-pricing-in-2025-in-tax-notes
31.
https://www.vitallaw.com/news/us-irs-drops-transfer-pricing-case-against-pharma-giant-perrigo/gdn01163640
32.
https://www.nytimes.com/2022/07/07/business/perrigo-omeprazole-taxes-ey.html
33.
https://investor.perrigo.com/2021-09-29-Perrigo-Resolves-Irish-Tax-Assessment-for-EUR297-million
34.
https://www.reuters.com/legal/government/us-judge-rules-against-perrigo-over-19-billion-irish-tax-liability-2021-07-16/
35.
https://www.law360.com/tax-authority/international/articles/2392644/perrigo-mostly-beats-us-in-163m-tax-refund-dispute
36.
https://www.ai-cio.com/news/florida-pensions-agree-to-settle-perrigo-lawsuit-for-31-9-million/
37.
https://www.algoodbody.com/insights-publications/news/settlement-of-irish-revenues-largest-tax-assessment
38. https://www.vitallaw.com/news/us-irs-drops-transfer-pricing-case-against-pharma-giant-perrigo/gdn01163640
39.
https://www.irishtimes.com/business/health-pharma/perrigo-agrees-300m-settlement-of-1-64bn-tax-assessment-1.4687034
40. https://investor.perrigo.com/2022-08-17-PERRIGO-RELEASES-STATEMENT-ON-RECENT-MARKET-TRADING-ACTIVITY





No comments:
Post a Comment